Loading insider details...
Beta
Latest Form 4 (Sep 15, 2026): Grant/Award of 5,020 NBIX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/Award | 5,020 | n/a |
| Jun 15, 2026 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 87,900 | n/a |
| Mar 5, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Gift | 2,249 | n/a |
| Feb 17, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 2,133 | n/a |
| Feb 3, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 2,437 | n/a |
| May 30, 2025 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 110,000 | n/a |
| Feb 14, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 2,566 | n/a |
| Feb 12, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 1,860 | n/a |
| Feb 4, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 2,436 | n/a |
| Aug 15, 2024 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 14,100 | $1.04M |